FDA.reportPublic FDA data

Caveolin IVD, antibody

Definition
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of a caveolin protein (e.g., CAV1) in a clinical specimen.
GUDID devices
14
Last updated
2025-03-05 15:16:59

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB33170Caveolin-1 RMabBIO SB, INC.Concentrate, 0.1 ml2020-03-16
B502BSB33180Caveolin-1 RMabBIO SB, INC.Concentrate, 0.5 ml2020-03-16
B502BSB33190Caveolin-1 RMabBIO SB, INC.Concentrate, 1 ml2020-03-16
00810113068602Rabbit Monoclonal Anti-Human Caveolin-1, EP353Epitomics Inc.AC-0320B2023-06-21
00810113068619Rabbit Monoclonal Anti-Human Caveolin-1, EP353Epitomics Inc.AC-0320BULK2023-06-21
00810113068589Rabbit Monoclonal Anti-Human Caveolin-1, EP353Epitomics Inc.AC-0320A2023-06-13
00810113068596Rabbit Monoclonal Anti-Human Caveolin-1, EP353Epitomics Inc.AC-03202023-06-13
00841683101635Caveolin-1 (SP43) Rabbit Monoclonal Primary AntibodyCELL MARQUE CORPORATION760-49512021-04-15
B502BSB33140Tinto Caveolin-1 RMabBIO SB, INC.Predilute, 3 ml2020-08-31
B502BSB33150Tinto Caveolin-1 RMabBIO SB, INC.Predilute, 7 ml2020-08-31
B502BSB33160Tinto Caveolin-1 RMabBIO SB, INC.Predilute, 15 ml2020-08-31
L502BSB3317Caveolin-1 RMabBIO SB, INC.Concentrate, 0.1 ml2020-03-16
L502BSB3318Caveolin-1 RMabBIO SB, INC.Concentrate, 0.5 ml2020-03-16
L502BSB3319Caveolin-1 RMabBIO SB, INC.Concentrate, 1 ml2020-03-16